- Home
- NSTS vs DTIL Comparison
NSTS vs DTIL Comparison
Compare NSTS & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- DTIL
- Stock Information
- Founded
- NSTS 1921
- DTIL 2006
- Country
- NSTS United States
- DTIL United States
- Employees
- NSTS N/A
- DTIL N/A
- Industry
- NSTS Savings Institutions
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- DTIL Health Care
- Exchange
- NSTS Nasdaq
- DTIL Nasdaq
- Market Cap
- NSTS 58.7M
- DTIL 55.3M
- IPO Year
- NSTS N/A
- DTIL 2019
- Fundamental
- Price
- NSTS $11.00
- DTIL $6.14
- Analyst Decision
- NSTS
- DTIL Strong Buy
- Analyst Count
- NSTS 0
- DTIL 2
- Target Price
- NSTS N/A
- DTIL $47.00
- AVG Volume (30 Days)
- NSTS 5.1K
- DTIL 185.6K
- Earning Date
- NSTS 11-14-2025
- DTIL 11-03-2025
- Dividend Yield
- NSTS N/A
- DTIL N/A
- EPS Growth
- NSTS N/A
- DTIL N/A
- EPS
- NSTS N/A
- DTIL N/A
- Revenue
- NSTS $9,435,000.00
- DTIL $698,000.00
- Revenue This Year
- NSTS N/A
- DTIL N/A
- Revenue Next Year
- NSTS N/A
- DTIL $135.19
- P/E Ratio
- NSTS N/A
- DTIL N/A
- Revenue Growth
- NSTS 69.39
- DTIL N/A
- 52 Week Low
- NSTS $10.72
- DTIL $3.61
- 52 Week High
- NSTS $13.32
- DTIL $8.82
- Technical
- Relative Strength Index (RSI)
- NSTS 41.39
- DTIL 43.74
- Support Level
- NSTS $11.00
- DTIL $6.18
- Resistance Level
- NSTS $11.26
- DTIL $8.77
- Average True Range (ATR)
- NSTS 0.14
- DTIL 0.66
- MACD
- NSTS 0.03
- DTIL -0.21
- Stochastic Oscillator
- NSTS 46.96
- DTIL 3.64
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.